Epidemiology and general guidelines of the management of acquired haemophilia and von Willebrand syndrome

被引：51

作者：

Collins, P. ^{[2
]}

Budde, U. ^{[3
]}

Rand, J. H.

Federici, A. B. ^{[4
]}

Kessler, C. M. ^{[1
]}

机构：

[1] Georgetown Univ, Med Ctr, Div Hematol Oncol, Lombardi Comprehens Canc Ctr, Washington, DC 20007 USA

[2] Univ Wales Hosp, Arthur Bloom Haemophilia Ctr, Cardiff, Wales

[3] Coagulat Lab, Hamburg, Germany

[4] Mangiagalli Regina Elena & Univ Milan, Angelo Bianchi Bonomi Hemophilia & Thrombosis Ctr, Fdn Maggiore Policlin Hosp,IRCCS, Dept Internal Med & Dermatol, Milan, Italy

来源：

HAEMOPHILIA | 2008年 / 14卷

关键词：

D O I：

10.1111/j.1365-2516.2008.01745.x

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：49 / 55

页数：7

共 34 条

[1] A population based, unselected, consecutive cohort of patients with acquired haemophilia A [J].

Collins, P ;

Macartney, N ;

Davies, R ;

Lees, S ;

Giddings, J ;

Majer, R .

BRITISH JOURNAL OF HAEMATOLOGY, 2004, 124 (01) :86-90

[2] Treatment of acquired hemophilia A [J].

Collins, P. W. .

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2007, 5 (05) :893-900

[3] Acquired hemophilia A in the United Kingdom: a 2-year national surveillance study by the United Kingdom Haemophilia Centre Doctors' Organisation [J].

Collins, Peter W. ;

Hirsch, Sybil ;

Baglin, Trevor P. ;

Dolan, Gerard ;

Hanley, John ;

Makris, Michael ;

Keeling, David M. ;

Liesner, Ri ;

Brown, Simon A. ;

Hay, Charles R. M. .

BLOOD, 2007, 109 (05) :1870-1877

[4] Acquired haemophilia: Review and meta-analysis focused on therapy and prognostic factors [J].

Delgado, J ;

Jimenez-Yuste, V ;

Hernandez-Navarro, F ;

Villar, A .

BRITISH JOURNAL OF HAEMATOLOGY, 2003, 121 (01) :21-35

[5] Safety of factor VIII inhibitor bypass activity (FEIBA®):: 10-year compilation of thrombotic adverse events [J].

Ehrlich, HJ ;

Henzl, MJ ;

Gomperts, ED .

HAEMOPHILIA, 2002, 8 (02) :83-90

[6] Acquired von Willebrand syndrome: an underdiagnosed and misdiagnosed bleeding complication in patients with lymphoproliferative and myeloproliferative disorders [J].

Federici, AB .

SEMINARS IN HEMATOLOGY, 2006, 43 (01) :S48-S58

[7]

Federici AB, 2000, THROMB HAEMOSTASIS, V84, P345

[8] Treatment of acquired von Willebrand syndrome in patients with monoclonal gammopathy of uncertain significance: Comparison of three different therapeutic approaches [J].

Federici, AB ;

Stabile, F ;

Castaman, G ;

Canciani, MT ;

Mannucci, PM .

BLOOD, 1998, 92 (08) :2707-2711

[9] Rituximab for the treatment of patients with very high-titre acquired factor VIII inhibitors refractory to conventional chemotherapy [J].

Field, J. J. ;

Fenske, T. S. ;

Blinder, M. A. .

HAEMOPHILIA, 2007, 13 (01) :46-50

[10] Immunoadsorption may provide a cost-effective approach to management of patients with inhibitors to FVIII [J].

Freedman, J ;

Rand, ML ;

Russell, O ;

Davis, C ;

Cheatley, PL ;

Blanchette, V ;

Garvey, MB .

TRANSFUSION, 2003, 43 (11) :1508-1513

← 1 2 3 4 →